<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02600650</url>
  </required_header>
  <id_info>
    <org_study_id>151004</org_study_id>
    <nct_id>NCT02600650</nct_id>
  </id_info>
  <brief_title>EndogenousTestosterone Response to a Testosterone Boosting Supplement</brief_title>
  <official_title>EndogenousTestosterone Response to a Testosterone Boosting Supplement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Memorial Chiropractic College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Iovate Health Sciences International Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Memorial Chiropractic College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a proprietary 'testosterone-boosting'
      supplement, when used as recommended by the manufacturer, results in an increase in
      testosterone levels as measured by a salivary free testosterone assay.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The experimental intervention in this study is the daily administration of a testosterone
      boosting supplement or sham supplement for 4 weeks. The supplement will be administered daily
      in capsule form. The control group will be given a sham capsule containing the carrier
      components of the supplement. Participants will be asked not to modify their current
      lifestyle. Salivary testosterone levels will be assessed prior to the intervention to collect
      a baseline measurement for each subject, and following the intervention to evaluate any
      changes in hormone levels.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in concentration of salivary free testosterone from baseline measured by ELISA</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in concentration of salivary free testosterone from baseline to 4 weeks will be measured by ELISA</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Testosterone</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive daily authentic Testosterone boosting supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Receive daily placebo supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Testosterone boosting supplement</intervention_name>
    <description>Proprietary formulation of Testosterone boosting supplement administered daily</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Comparator</intervention_name>
    <description>Daily administration of Placebo Comparator</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male aged 20 to 40 years.

          -  Fluent in English.

        Exclusion Criteria:

          -  Currently receiving hormonal therapy or testosterone boosting supplement.

          -  Has received hormonal therapy or testosterone boosting supplement within 3 months
             prior to study.

          -  Has experienced adverse event following previous exposure to testosterone boosting
             supplements.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>brian budgell, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Canadian Memorial Chiropractic College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mark fillery, B.A.</last_name>
    <phone>+1 416 482-2340</phone>
    <phone_ext>267</phone_ext>
    <email>mfillery@cmcc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>brian budgell, Ph.D.</last_name>
    <phone>+1 416 482-2340</phone>
    <phone_ext>151</phone_ext>
    <email>bbudgell@cmcc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Canadian Memorial Chiropractic College</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2H 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>mark fillery, B.A.</last_name>
      <phone>+1 416 482-2340</phone>
      <phone_ext>267</phone_ext>
      <email>mfillery@cmcc.ca</email>
    </contact>
    <contact_backup>
      <last_name>brian budgell, Ph.D.</last_name>
      <phone>+1 416 482-2340</phone>
      <phone_ext>151</phone_ext>
      <email>bbudgell@cmcc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>brian budgell, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2015</study_first_submitted>
  <study_first_submitted_qc>November 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2015</study_first_posted>
  <last_update_submitted>November 6, 2015</last_update_submitted>
  <last_update_submitted_qc>November 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Canadian Memorial Chiropractic College</investigator_affiliation>
    <investigator_full_name>Brian Budgell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

